Pharmadrug Inc.
PHRX
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 94.80K | 109.30K | 161.20K | 320.30K | 139.30K |
| Total Receivables | 12.20K | 44.60K | 48.60K | 14.50K | 722.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 40.70K | 40.20K | 3.70K | 3.80K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 100.50K | 112.80K | -- |
| Total Current Assets | 147.80K | 194.00K | 314.00K | 451.50K | 862.00K |
|
|
|||||
| Total Current Assets | 147.80K | 194.00K | 314.00K | 451.50K | 862.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | 0.00 | 0.00 | 0.00 | -- | 4.61M |
| Goodwill | 0.00 | 0.00 | 0.00 | -- | 4.61M |
| Total Other Intangibles | 416.20K | 422.20K | 436.00K | 456.60K | 3.35M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.20K | -- | -- | -- | -- |
| Total Assets | 566.20K | 616.20K | 750.00K | 908.00K | 8.83M |
|
|
|||||
| Total Accounts Payable | 253.80K | 257.80K | 325.20K | 340.40K | 476.80K |
| Total Accrued Expenses | 241.90K | 238.80K | 293.00K | 339.70K | 274.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.04M | 978.50K | 1.00M | 1.34M | 1.18M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.53M | 1.48M | 1.62M | 2.02M | 1.94M |
|
|
|||||
| Total Current Liabilities | 1.53M | 1.48M | 1.62M | 2.02M | 1.94M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 798.60K |
| Total Liabilities | 1.53M | 1.48M | 1.62M | 2.02M | 2.73M |
|
|
|||||
| Common Stock & APIC | 25.20M | 24.85M | 25.07M | 25.15M | 23.08M |
| Retained Earnings | -28.94M | -28.44M | -28.65M | -29.00M | -18.82M |
| Treasury Stock & Other | 2.64M | 2.60M | 2.56M | 2.56M | 1.61M |
| Total Common Equity | -1.09M | -991.80K | -1.02M | -1.29M | 5.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.09M | -991.80K | -1.02M | -1.29M | 5.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 127.40K | 132.80K | 143.80K | 180.90K | 221.80K |
| Total Equity | -967.10K | -858.90K | -872.10K | -1.11M | 6.09M |
|
|
|||||
